Valuation: IRRAS AB (publ)

Market Cap 182M 18.71M 16.4M 15.12M 14.16M 26.55M 1.76B 27.1M 70.33M 872M 70.25M 68.72M 3.02B P/E 2023
-0.73x
P/E 2024 -1.89x
Enterprise Value 396M 40.72M 35.7M 32.91M 30.81M 57.77M 3.84B 58.97M 153M 1.9B 153M 150M 6.58B EV / Sales 2023
5.26x
EV / Sales 2024 6.82x
Free-Float
3.55%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 51 2021-06-30
Director of Finance/CFO 40 2021-06-16
Investor Relations Contact - 2021-03-08
Director TitleAgeSince
Director/Board Member 68 2015-05-31
Chairman 53 2020-08-17
Director/Board Member 71 2017-08-31
Change 5-day change 1-year change 3-year change Capi.($)
-3.63%-70.75% - - 16.9M
+5.25%+8.09%-14.78%+12.08% 128B
-0.65%+1.20%+3.41%-8.11% 12.77B
+1.30%+10.51%+42.91%+109.94% 8.48B
-3.88%-6.41%-50.34%-72.89% 3.79B
-0.38%-0.97%+17.98%+37.20% 2.52B
-9.06%+4.50%+229.48%+156.69% 1.55B
-8.75%-13.25%-26.46%-23.39% 1.53B
-2.80%-3.48%-1.78%-22.72% 1.53B
Average -2.51%-0.05%+25.05%+23.60% 19.96B
Weighted average by Cap. +3.91%+6.82%-8.20%+14.78%

Financials

2023 2024
Net sales 42.88M 4.41M 3.87M 3.57M 3.34M 6.26M 416M 6.39M 16.59M 206M 16.58M 16.21M 714M 57.98M 5.97M 5.23M 4.82M 4.52M 8.47M 563M 8.65M 22.44M 278M 22.41M 21.92M 965M
Net income -209M -21.5M -18.85M -17.38M -16.27M -30.51M -2.03B -31.14M -80.82M -1B -80.74M -78.98M -3.48B -95.98M -9.88M -8.66M -7.99M -7.48M -14.02M -932M -14.31M -37.14M -461M -37.1M -36.29M -1.6B
Net Debt 43.85M 4.51M 3.96M 3.65M 3.42M 6.4M 426M 6.54M 16.97M 210M 16.95M 16.58M 730M 214M 22.01M 19.3M 17.79M 16.65M 31.23M 2.08B 31.87M 82.72M 1.03B 82.64M 80.84M 3.56B
Logo IRRAS AB (publ)
Irras AB is Sweden- based medical device company primarily engaged in develops and commercializes solutions that are designed to transform neurocritical care. Company focus on neurosurgical procedures, where excess cerebrospinal fluid (CSF) or toxic blood byproducts often need to be emergently drained and intracranial pressure (ICP) needs to be closely regulated.
Employees
43